2015
Recombinant Human Antithrombin in Pregnant Patients with Hereditary Antithrombin Deficiency: Integrated Analysis of Clinical Data
Paidas MJ, Triche EW, James AH, DeSancho M, Robinson C, Lazarchick J, Ornaghi S, Frieling J. Recombinant Human Antithrombin in Pregnant Patients with Hereditary Antithrombin Deficiency: Integrated Analysis of Clinical Data. American Journal Of Perinatology 2015, 33: 343-349. PMID: 26461927, DOI: 10.1055/s-0035-1564423.Peer-Reviewed Original ResearchConceptsRecombinant human antithrombinVenous thromboembolismPregnant patientsDoses of anticoagulationHigh VTE riskPostpartum venous thromboembolismHereditary antithrombin deficiencyHuman antithrombinOnset of laborAnticoagulation therapyVTE eventsVTE riskCesarean deliveryTherapy durationProphylactic dosesWeight heparinPeripartum periodClinical trialsClinical dataAntithrombin deficiencyPatientsBody weightIU/TherapyDoses
2013
347: Recombinant human antithrombin (rhAT) for prevention of venous thromboembolism (VTE) in pregnant patients with hereditary antithrombin deficiency (HD)
Paidas M, Triche E, James A, Ballard T, Lowry S. 347: Recombinant human antithrombin (rhAT) for prevention of venous thromboembolism (VTE) in pregnant patients with hereditary antithrombin deficiency (HD). American Journal Of Obstetrics And Gynecology 2013, 208: s154. DOI: 10.1016/j.ajog.2012.10.512.Peer-Reviewed Original Research